Emergent BioSolutions Inc. is a multinational specialty biopharmaceutical company headquartered in Toronto that develops vaccines and therapeutics for infectious diseases and opioid overdoses. The company is committed to delivering protective and life-saving solutions to communities around the world. A key focus area is addressing Canada's opioid crisis through the development and distribution of opioid-poisoning treatments such as NARCAN® Nasal Spray. Emergent operates as a leading public health company with a culture informed by values centered on protecting and saving lives.
Industry
Biopharmaceutical
Remote Policy
Remote-first
Beta · Sourced from candidate reports
Be the first to share your experience with Emergent BioSolutions.
Your reply helps other candidates know what to expect.
